Cargando…

Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer

The standard treatment for locally advanced non‐small cell lung cancer (NSCLC) is chemoradiotherapy (CRT) followed by anti‐programmed cell death‐ligand 1 (anti‐PD‐L1) treatment. BIM deletion polymorphism induces the suppression of apoptosis resulting from epidermal growth factor (EGFR)‐tyrosine kina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wakabayashi, Yu, Masuda, Takeshi, Fujitaka, Kazunori, Nakashima, Taku, Okumoto, Joe, Shimoji, Kiyofumi, Nishimura, Yoshifumi, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Horimasu, Yasushi, Miyamoto, Shintaro, Iwamoto, Hiroshi, Ohshimo, Shinichiro, Hamada, Hironobu, Hattori, Noboru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780054/ https://www.ncbi.nlm.nih.gov/pubmed/33103296 http://dx.doi.org/10.1111/cas.14711

Ejemplares similares

AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2017)

Pneumatosis Intestinalis following Radiation Esophagitis during Chemoradiotherapy for Lung Cancer: A Case Report
por: Ito, Noriaki, et al.
Publicado: (2021)

Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2018)

IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
por: Nakanishi, Yu, et al.
Publicado: (2021)

Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2020)

A machine-learning based approach to quantify fine crackles in the diagnosis of interstitial pneumonia: A proof-of-concept study
por: Horimasu, Yasushi, et al.
Publicado: (2021)

Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma
por: Okumoto, Joe, et al.
Publicado: (2020)

Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression
por: Shimoji, Kiyofumi, et al.
Publicado: (2023)

Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
por: Horimasu, Yasushi, et al.
Publicado: (2021)

Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers
por: Shimoji, Kiyofumi, et al.
Publicado: (2020)

Pulmonary Alveolar Proteinosis with Severe Respiratory Failure Improved by Segmental Lung Lavage with Fiberoptic Bronchoscopy under General Anesthesia
por: Matsumoto, Yu, et al.
Publicado: (2021)

Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case report
por: Nakao, Satoshi, et al.
Publicado: (2019)

High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery
por: Takao, Shun, et al.
Publicado: (2019)

Performance Status Is a Risk Factor for Depression before the Diagnosis of Lung Cancer Patients
por: Miwata, Kei, et al.
Publicado: (2018)

D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report
por: Matsumoto, Yu, et al.
Publicado: (2021)

Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial–mesenchymal transition in lung endothelial cells
por: Daido, Wakako, et al.
Publicado: (2023)

Chronic Intestinal Pseudo-obstruction and Orthostatic Hypotension Associated with Small Cell Lung Cancer that Improved with Tumor Reduction after Chemoradiotherapy
por: Izumi, Yusuke, et al.
Publicado: (2017)

Preserved ratio impaired spirometry with or without restrictive spirometric abnormality
por: Miura, Shinichiro, et al.
Publicado: (2023)

Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive‐stage small cell lung cancer: Two case reports
por: Watari, Naokazu, et al.
Publicado: (2021)

Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
por: Takahashi, Hiroshi, et al.
Publicado: (2021)

Two Cases of Cranial Nerve Metastasis Treated with Radiotherapy and Chemotherapy in Patients with Lung Adenocarcinoma
por: Kobayashi, Erika, et al.
Publicado: (2020)

Pneumonia and Meningoencephalitis Due to Varicella-zoster Virus Reinfection and Epstein-Barr Virus Reactivation in a Patient with Rheumatoid Arthritis
por: Ito, Noriaki, et al.
Publicado: (2022)

Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis
por: Yamada, Takahiro, et al.
Publicado: (2019)

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis
por: Hamai, Kosuke, et al.
Publicado: (2016)

Inhibition of PAI‐1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer‐associated fibroblasts
por: Masuda, Takeshi, et al.
Publicado: (2019)

Pulmonary arteriovenous malformation exhibiting recanalization >10 years after coil embolization: Two case reports
por: Takao, Shun, et al.
Publicado: (2020)

First‐line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptor G719S and de novo T790M mutations
por: Ito, Noriaki, et al.
Publicado: (2022)

Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
por: Takao, Shun, et al.
Publicado: (2021)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition
por: Tokumo, Kentaro, et al.
Publicado: (2023)

Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis
por: Namba, Masashi, et al.
Publicado: (2017)

Plasminogen activator inhibitor-1 serves an important role in radiation-induced pulmonary fibrosis
por: Shioya, Sachiko, et al.
Publicado: (2018)

Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with the High Expression of IgG4
por: Tanahashi, Hiroki, et al.
Publicado: (2021)

Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2021)

Association Between Patient Preference for Inhaler Medications and Asthma Outcomes
por: Nakanishi, Yu, et al.
Publicado: (2022)

Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
por: Watari, Naokazu, et al.
Publicado: (2022)

MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study
por: Horimasu, Yasushi, et al.
Publicado: (2017)

Intratracheal Administration of siRNA Dry Powder Targeting Vascular Endothelial Growth Factor Inhibits Lung Tumor Growth in Mice
por: Miwata, Kei, et al.
Publicado: (2018)

Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer
por: Masuda, Takeshi, et al.
Publicado: (2020)

Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets
por: Horimasu, Yasushi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1jiq47bsa99h9fkjcacqh755ce